About
Company Strategy
Group Structure
Board of directors
Management
Career
Contacts
Development
Drugs
Medical devices
Medical services
Biotech valuation
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Investor
Disclosure of information
News
En
RU
CN
Главная
News
News
News, press releases, events, publications
Press releases
All categories
Portfolio
Portfolio
Genetico
Gemabank
Histograft
Nextgen
Genotarget
Biotechnology Developments
Betuvax
17.04.2024
Press releases
Genetico shares are included in the new Moscow Exchange index
05.04.2024
Press releases
Artgen Biotech invests in the development of gene-activated materials
28.03.2024
Press releases
Genetico results for 12 months of 2023
25.03.2024
Press releases
Gemabank results for 2023 according to RAS
20.03.2024
Press releases
Artgen Biotech will not conduct SPO
12.02.2024
Press releases
RBT conducted preclinical studies of a new immunomodulating drug
01.02.2024
Press releases
ALOR BROKER published an analytical report on Gemabank
1
2
3
4
5
6
…
10
Up
About the Company
About
Company Strategy
Group Structure
Board of Directors
Management
Career
Contacts
Development Portfolio
Drugs
Medical Devices
Medical Services
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Biotech Valuation
Investors
Disclosure of information